Market Insight - Time for patent pools to make their mark?
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline has become the first pharmaceutical company to establish a patent pool with the aim of promoting research into neglected tropical diseases. How robust is this strategy when held up to closer scrutiny, asks Elizabeth Sukkar